Australia-based Telix Pharmaceuticals has signed a strategic agreement to lead a merger with ITM Isotope Technologies Munich SE, a global leader in radioisotope production and radiopharmaceutical ...

To further enhance Taiwan’s role in global clinical research and innovative drug development, accelerate the advancement of cutting-edge medical technologies, and improve patient access to innovative ...

South Korea-based 1ST Biotherapeutics, Inc. and SK Biopharmaceuticals have entered into an exclusive global licensing agreement and strategic equity investment (SI) partnership to advance 1ST-104, a ...

Swiss pharma firm Roche has announced the grand opening of the Roche Genentech Innovation Center Boston, expanding Roche and Genentech's US research presence in one of the world's leading life ...

University of Sydney and Northern NSW Local Health District join forces to build rural health workforce in Australia ...

Japan-based company NIPRO has maintained a presence in Singapore since 1997. Ahead of NIPRO Asia's 30th anniversary in 2027, ...

Israeli medical technology company P-Cure and Indian healthcare company ARISTION Proton Centre have announced the signing of ...

Under the terms of the agreement, China-based WuXi XDC will grant Ona Therapeutics an exclusive global license to its ...

Swiss firm Tenthpin expands footprint in India with AI, IoMT-based Centre for Life Sciences Innovation Hub in Bengaluru ...

To enable faster, easier and more flexible RNA-to-cDNA synthesis, Thermo Fisher Scientific has introduced Invitrogen™ ...

Japan-based Takeda Pharmaceutical Company, through its Indian subsidiary Takeda Biopharmaceuticals India, and Dr. Reddy’s ...

All deal values reflect company disclosures. Where parties have not disclosed terms, they are reported as undisclosed. No ...